Pancreatic Cancer Research

ResearcherConsejo Superior de Investigaciones CientíficasNo recent work listed

Daniel Closa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3797-3095; OpenAlex author ID A5081153974. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 4

  1. Pancreatic cancer, stroma, and exosomes. Co-author DOI 10.1007/s13105-022-00898-1↗
  2. Targeting REG3β limits pancreatic ductal adenocarcinoma progression through CTGF downregulation. First author DOI 10.1016/j.canlet.2021.08.024↗
  3. Factors released by the tumor far microenvironment are decisive for pancreatic adenocarcinoma development and progression. First author DOI 10.1080/2162402x.2017.1358840↗
  4. IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-15-0896↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Iovanna · 3 shared papers, 2015–2021 · strength 0.34
  2. Emma Folch‐Puy · 2 shared papers, 2015–2021 · strength 0.19
  3. Eduardo Chuluyán · 2 shared papers, 2015–2021 · strength 0.19
  4. Analía Meilerman Abuelafia · 1 shared paper, 2021 · strength 0.15
  5. Nicolas Alejandro Fraunhoffer · 1 shared paper, 2021 · strength 0.15
  6. Céline Loncle · 1 shared paper, 2015 · strength 0.04
  7. María Inés Molejon · 1 shared paper, 2015 · strength 0.04
  8. Raul A. Urrutia · 1 shared paper, 2015 · strength 0.04
  9. Gwen Alyce Lomberk · 1 shared paper, 2015 · strength 0.04
  10. Pierre Cordelier · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.